BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11018224)

  • 1. Signaling: cellular insights into the pathophysiology of bipolar disorder.
    Manji HK; Lenox RH
    Biol Psychiatry; 2000 Sep; 48(6):518-30. PubMed ID: 11018224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the mechanism of action of lithium in the brain: fifty-year update.
    Lenox RH; Hahn CG
    J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
    Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
    Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiology of lithium: an update.
    Lenox RH; McNamara RK; Papke RL; Manji HK
    J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of bipolar disorder.
    Manji HK; Lenox RH
    J Clin Psychiatry; 2000; 61 Supp 13():42-57. PubMed ID: 11153812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction pathways. Molecular targets for lithium's actions.
    Manji HK; Potter WZ; Lenox RH
    Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
    Manji HK; Chen G
    Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders.
    Manji HK; Chen G
    Curr Psychiatry Rep; 2000 Dec; 2(6):479-89. PubMed ID: 11122999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.
    Hahn CG; Friedman E
    Bipolar Disord; 1999 Dec; 1(2):81-6. PubMed ID: 11252663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.
    Stewart RJ; Chen B; Dowlatshahi D; MacQueen GM; Young LT
    Brain Res Bull; 2001 Jul; 55(5):625-9. PubMed ID: 11576759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
    Einat H; Chen G; Manji H
    Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathology of bipolar disorders: what have changed in the last 10 years?].
    Kapczinski F; Frey BN; Zannatto V
    Braz J Psychiatry; 2004 Oct; 26 Suppl 3():17-21. PubMed ID: 15597134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular model for bipolar affective disorder.
    Lachman HM; Papolos DF
    Med Hypotheses; 1995 Sep; 45(3):255-64. PubMed ID: 8569548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness.
    Manji HK; Lenox RH
    Biol Psychiatry; 1999 Nov; 46(10):1328-51. PubMed ID: 10578449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.
    Quiroz JA; Singh J; Gould TD; Denicoff KD; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):756-76. PubMed ID: 15136795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
    Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of lithium: intracellular signaling pathways].
    Zorrilla Zubilete M
    Vertex; 2003; 14(51):45-52. PubMed ID: 12690409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postreceptor pathways for signal transduction in depression and bipolar disorder.
    Young LT
    J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S17-22. PubMed ID: 11590965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurobiology of bipolar disorder: findings using human postmortem central nervous system tissue.
    Dean B
    Aust N Z J Psychiatry; 2004 Mar; 38(3):135-40. PubMed ID: 14961931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.